Shareholders that lost money on Sage Therapeutics, Inc. (SAGE) Urged to Join Class Action – Contact Levi & Korsinsky to Learn MoreGlobeNewsWire • 10/14/24
Sage Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SAGEAccesswire • 10/14/24
Levi & Korsinsky Notifies Sage Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SAGEAccesswire • 10/14/24
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage TherapeuticsPRNewsWire • 10/14/24
Levi & Korsinsky Reminds Sage Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGEAccesswire • 10/14/24
Lost Money on Sage Therapeutics, Inc.(SAGE)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyAccesswire • 10/14/24
SAGE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sage Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/14/24
Investors who lost money on Sage Therapeutics, Inc.(SAGE) should contact The Gross Law Firm about pending Class Action - SAGEPRNewsWire • 10/14/24
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc.(SAGE) ShareholdersAccesswire • 10/13/24
SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sage Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/13/24
ROSEN, A LEADING LAW FIRM, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGEGlobeNewsWire • 10/12/24
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAGEAccesswire • 10/11/24
Shareholders That Lost Money on Sage Therapeutics, Inc. (SAGE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 10/11/24
SAGE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sage Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/11/24
Sage Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - SAGEAccesswire • 10/10/24
SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sage Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/10/24
Sage Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - SAGEPRNewsWire • 10/10/24
SAGE's Dalzanemdor Fails to Meet Goal in Alzheimer's Disease StudyZacks Investment Research • 10/09/24
SAGE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $00,000 In XXX To Contact Him Directly To Discuss Their OptionsPRNewsWire • 10/09/24
Sage Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – SAGEAccesswire • 10/08/24
Sage Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights – SAGEGlobeNewsWire • 10/08/24
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Sage Therapeutics, Inc. Lawsuit - SAGEAccesswire • 10/08/24
After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's StudyBenzinga • 10/08/24
